Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study): 1-year results (Q86423891)
Jump to navigation
Jump to search
scientific article published on 01 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study): 1-year results |
scientific article published on 01 June 2013 |
Statements
Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study): 1-year results (English)
Ingrid U Scott
Léssia P Cintra
Daniela Calucci